Antiviral adaptive immune responses, including those mediated by effector antigen-specific CD4+ and CD8+ T cells, are required for the regulation of JE progression through the control and clearance of JEV in extraneural lymphoid tissues and the CNS [36–38]. This evidence concerns the gene CD4 and Japanese encephalitis.